The concept of Gen-eye® was conceived in 2009, prompted by the clear need for a company with the ability to provide ophthalmologists and patients with a new treatment approach comprising a comprehensive basket of cost-effective, quality ophthalmics from world-class manufacturers.
As found in first-world countries, quality generics with a longstanding heritage play a vital role in increasing access, affordability and availability of medicines to patients; particularly in chronic debilitating conditions such as glaucoma.
